ReviewPharmaceutics2022

Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis.

Toshihiko TashimaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.